Back
Y-mAbs Therapeutics Vs. Moderna Industry Stock Comparison
Sell
35
YMAB
Y-mAbs Therapeutics
Last Price:
12.20
Seasonality Move:
18.11%
Sell
46
MRNA
Moderna
Last Price:
117.80
Seasonality Move:
35.29%
Sell
35
Y-mAbs Therapeutics (YMAB)
is a Sell
Is Y-mAbs Therapeutics a Buy, Sell or Hold?
- The current Y-mAbs Therapeutics [YMAB] share price is $12.87. The Score for YMAB is 35, which is 30% below its historic median score of 50, and infers higher risk than normal.
- YMAB is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
46
Moderna (MRNA)
is a Sell
Is Moderna a Buy, Sell or Hold?
- The current Moderna [MRNA] share price is $122.69. The Score for MRNA is 46, which is 8% below its historic median score of 50, and infers higher risk than normal.
- MRNA is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
YMAB Stock Price Chart
What is Y-mAbs Therapeutics's stock price today?
-
The Y-mAbs Therapeutics share price today is $12.87
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and YMAB is experiencing selling pressure, which indicates risk of future bearish movement.
MRNA Stock Price Chart
YMAB Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0 | Sell |
| Relative Strength Index (14 RSI): | 34.3 | Sell |
| Chaikin Money Flow: | -507827 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (14.03 - 16.29) | Sell |
| Bollinger Bands (100): | (9.68 - 16.9) | Sell |
MRNA Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 4.94 | Buy |
| Relative Strength Index (14 RSI): | 67.04 | Buy |
| Chaikin Money Flow: | -1446808 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (102.75 - 118.09) | Buy |
| Bollinger Bands (100): | (93.75 - 111.27) | Buy |
YMAB Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 15.88 | Sell |
| 20-day SMA: | 15.38 | Sell |
| 50-day SMA: | 15.62 | Sell |
| 200-day SMA: | 9.42 | Buy |
| 8-day EMA: | 15.23 | Sell |
| 20-day EMA: | 15.4 | Sell |
| 50-day EMA: | 14.97 | Sell |
| 200-day EMA: | 11.21 | Buy |
MRNA Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 120.02 | Buy |
| 20-day SMA: | 111.34 | Buy |
| 50-day SMA: | 106.92 | Buy |
| 200-day SMA: | 98.4 | Buy |
| 8-day EMA: | 119.58 | Buy |
| 20-day EMA: | 114.07 | Buy |
| 50-day EMA: | 107.98 | Buy |
| 200-day EMA: | 106.48 | Buy |
Y-mAbs Therapeutics Earnings Growth & YMAB Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.07 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.23 per share, and an increase next year of $0.27 per share.
Moderna Earnings Growth & MRNA Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.90 per share, a decrease next quarter of $1.65 per share, an increase this year of $6.35 per share, and an increase next year of $2.02 per share.
Y-mAbs Therapeutics Technical Analysis
| Apr 26 | Apr 29 | Apr 30 | May 1 | May 2 | May 3 | May 6 | May 7 | May 8 | May 9 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr | May | |||||||||
| 26 | 29 | 30 | 01 | 02 | 03 | 06 | 07 | 08 | 09 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Moderna Technical Analysis
| Apr 26 | Apr 29 | Apr 30 | May 1 | May 2 | May 3 | May 6 | May 7 | May 8 | May 9 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr | May | |||||||||
| 26 | 29 | 30 | 01 | 02 | 03 | 06 | 07 | 08 | 09 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||